1. 1
InTraCoM GmbH | Sigmaringerstr. 35 | 70567 Stuttgart (Möhringen) | Tel.: +49 (0) 711/ 797 328-0 | Fax: +49 (0) 711/ 797 328-29 | Internet: www.intracomgroup.de
Stuttgart, 28. October 2016, Prof. Dipl.-Ing. Andreas Zagos (Management Partner InTraCoM GmbH)
Transatlantic Trade and Investment Partnership [TTIP]
OVERPERFOMERS
TTIP in general
TTIP will bring opportunities to different
branches. Studies expect EU and US exports to
the rest of the world would increase by over €33
billion and €80 billion respectively, mainly
reflecting the fact that at least part of the cost
savings can be achieved.
The main question is to which branches, and
which companies (small-, mid-, or large-caps) will
have the highest benefits?
Different studies1
show that prevailing winners
will be
- Mainly large- to mid cap companies
- All branches with high regulatory
standards: medical devices, machinery,
automotive, chemicals, food, metals and
–products und „other“
At the moment, many EU and U.S. standards are
comparable but not mutually recognized. This
leads to increased costs on both sides of the
Atlantic; for instance many products have to go
through safety tests twice in order to be certified
in both regions. Better compatibility would lead
to huge savings and an increase in trade.
1
http://www.bfna.org/sites/default/files/TTIP-
GED%20study%2017June%202013.pdf
According to the CEPR study2
EU exports would
increase in almost all sectors as a result of the
TTIP, but the boost in total EU exports outside
the Single Market would be particularly
significant in metal products (+12%), processed
foods (+9%), chemicals (+9%), other
manufactured goods (+6%), other transport
equipment (+6%), and especially in motor
vehicles (41%).
Description of the basic idea
The basic idea of this study is to identify ideal
companies from US and EU which are in the
certain mentioned above branches, have a high
relative innovation strength and prepare
themselfes for increasing their business in the
other transatlantic region.
The IP Value indicators can perform in this case in
the exact way: they can identify companies with
increasing IP value (and relative high IP value
compared to total assets) and the patent portfolio
shows a significant increase in patent portfolio
growth (applications and grants) in the other
transatlantic region (EU companies increasing
patent activity in US and vice versa).
2
http://trade.ec.europa.eu/doclib/docs/2013/march/tradoc_150737.pdf

2. 2
InTraCoM GmbH | Sigmaringerstr. 35 | 70567 Stuttgart (Möhringen) | Tel.: +49 (0) 711/ 797 328-0 | Fax: +49 (0) 711/ 797 328-29 | Internet: www.intracomgroup.de
Conclusion
On the above graph are samples of companies
which are in the healthcare branch and listed at
the stock exchange. In the first set are companies
with Headquarter in Europe. In this sample only
the companies “Fresenius”, Coloplast and
“Grifolds” have a very positive TTIP rating,
because the IP values and number of patents in
US increase disproportionate to their home
market which is Europe.
In the second set of the list are companies with
Headquarter in US. Here only Amgen has a clear
overperformance in increasing IP values in
Europe. Thermo Fischer is as well rated positive
due the strong increase in Europe.
About the Author
Prof. Dipl.-Ing. Andreas Zagos is founder and
management Partner of the Stuttgart based
InTraCoM GmbH (Germany) and internationally
recognized patent valuation expert. He was
participating in the first standard for patent
valuation and is doing research in patent
valuation for more than 16 years.
He is guest professor at the Technical University
of Cluj-Napoca in the field of innovation
management.
InTraCoM GmbH is a patent valuation boutique
with a long list of patent valuation customers.
InTraCoM GmbH is performing patent valuations
for M&A, patent transactions, licensing value
determination, internal balancing purposes, sale
and lease back, transfer pricing and many more
valuation scopes. Their customers are
international big blue chip companies,
governmentals, banks, official authorities, SMEs,
Universities as well as big research organisations.
InTraCoM Group is supported by different
international partners offering patent
Valuation -specific data and business information.
Within these partnerships also software and
patent valuation-specific data can be offered
based the InTraCoM-patent valuation
methodology. With all these approaches, patent
values can be determined within unbeatable
precision, time and cost.